News | September 21, 2009

CardiacAssist Partners with Mentice to Showcase Transseptal Puncture Training Simulation

September 21, 2009 — CardiacAssist Inc. announced today that it will showcase transseptal puncture training simulation, developed by Mentice Inc., at its TandemHeart® System exhibit in San Francisco at the “Transcatheter Therapeutics (TCT) 2009” Annual Scientific Session next week. TandemHeart is the only 5 lpm net flow, percutaneous "extracorporeal circulatory support" device approved by the FDA for sale in the U.S. The TandemHeart device can be placed rapidly in a cath lab or an operating room—providing effective, reliable, temporary circulatory support for critically ill patients. TandemHeart is fully reimbursed by Medicare under existing DRG codes.

While transseptal puncture of the interatrial septum was introduced nearly 50 years ago, it remains a difficult procedure. Renewed interest in transseptal left heart catheterization is on the rise due to the development of left side catheter ablation and the emergence of percutaneous technologies to treat mitral and aortic valve disease. Indeed, the transseptal puncture technique has now been used in more than 1,500 TandemHeart cases by more than 300 physicians.

“We believe it is imperative for cardiologists to be knowledgeable about the transseptal puncture technique, and the Mentice training simulation is designed to show them how to perform a simple and safe transseptal puncture,” said CardiacAssist CEO Michael Garippa. “We are pleased to be partnering with Mentice to offer cardiologists the best simulation-training possible, and we expect to train more than 1,000 physicians as soon as possible to be ‘Tandem-ready’.”

“TCT 2009” will be held at the Moscone Convention Center in San Francisco, Sept. 21-25, 2009. CardiacAssist will be in booth number 2005 with information and displays pertaining to the TandemHeart System. Additionally, CardiacAssist will host a symposium—“Clinical Innovations and TandemHeart™ Support”—by invitation only on Thursday, Sept. 24th, from 6-8 p.m. at Morton’s Steak House, 400 Post Street.

The Symposium will feature presentations of cases that have saved patients’ lives at leading medical institutions across the country; presenters will include: Dr. Steven Burstein, Good Samaritan Hospital, Los Angeles; Dr. Kirk Garrett, Lenox Hill Hospital, New York City; and Dr. Srijoy Mahapatra, University of Virginia Health System, Charlottesville, Va. Current and prospective customers who are interested in attending the Symposium should visit CardiacAssist’s booth to receive an invitation.

To RSVP for the event, please contact Monica Bush at 412-963-7770, extension 247 or via email at [email protected]

Related Content

Sponsored Content | Videos | Cardiovascular Ultrasound| July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD)| June 30, 2017
Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic support with the...
Italian Boy Becomes Youngest Patient Bridged to Transplant With SynCardia Total Artificial Heart

Andrei, 12, is the world’s youngest patient to be bridged to transplant with the SynCardia Total Artificial Heart. He is pictured after his heart transplant with his surgeon, Antonio Amodeo, M.D., at Bambino Gesù Children’s Hospital in Rome, Italy. Photo courtesy of Business Wire.

News | Congenital Heart| June 22, 2017
A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s youngest patient to be...
Abiomed Impella CP pVAD, third-generation CP
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — Abiomed Inc.
tandemLife Tandemheart priming tray cleared by FDA
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — TandemLife began its commercial launch of the TandemLife Priming Tray, a new product designed to simp
Sponsored Content | Videos | Cardiovascular Ultrasound| May 26, 2017
This video, provided in partnership with the American Society of Echocardiography (ASE), is titled "Intraoperative Tr
Impella CP study to investigate door to left ventricular unloading time
News | May 09, 2017
May 9, 2017 — The first patient has been enrolled in the U.S.
Heartware HVAD recall for its ventricular assist device from Medtronic
Feature | Ventricular Assist Devices (VAD)| May 05, 2017
May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist De
the Impella pVAD improves survival, mortality in AMI heart attack with cardiogenic shock

Early use of the Impella percutaneous ventricular assist device prior to angioplasty may significantly improve survival for patients in cardiogenic shock.

Feature | Hemodynamic Support Devices| April 28, 2017 | Dave Fornell
Recent clinical study data presented at the American College of Cardiology (ACC) 2017 meeting show new treatment prot
Sponsored Content | Videos | Ventricular Assist Devices (VAD)| April 14, 2017
A discussion with William O'Neill, M.D., FACC, FSCAI, medical director of the Center for Structural Heart Disease at
Overlay Init